Orphan / Specialty Drugs Treatment Solutions
Browse premium Orphan & Specialty Drug brands covering rare disease therapies, gene treatments, enzyme replacement solutions, and advanced biologics approved for underserved patient populations worldwide.
Dupixent
Dupilumab
Soliris
Eculizumab
Ultomiris
Ravulizumab
Spinraza
Nusinersen
Evrysdi
Risdiplam
Vyvgart
Efgartigimod Alfa
Carvykti
Ciltacabtagene Autoleucel
Elevidys
Delandistrogene Moxeparvovec
Hemgenix
Etranacogene Dezaparvovec
Hemlibra
Emicizumab
Zolgensma
Onasemnogene Abeparvovec
Fabrazyme
Agalsidase Beta
Cerezyme
Imiglucerase
Vpriv
Velaglucerase Alfa
Replagal
Agalsidase Alfa
Elaprase
Idursulfase
Naglazyme
Galsulfase
Aldurazyme
Laronidase
Myozyme / Lumizyme
Alglucosidase Alfa
Kanuma
Sebelipase Alfa
Strensiq
Asfotase Alfa
Translarna
Ataluren
Exondys 51
Eteplirsen
Vyondys 53
Golodirsen
Viltepso
Viltolarsen
Amondys 45
Casimersen
Palynziq
Pegvaliase-pqpz
Kuvan
Sapropterin Dihydrochloride
Crysvita
Burosumab
Tegsedi
Inotersen
Onpattro
Patisiran
Amvuttra
Vutrisiran
Vyndaqel / Vyndamax
Tafamidis Meglumine / Tafamidis
Procysbi
Cysteamine Bitartrate Delayed-release
Acthar Gel
Repository Corticotropin Injection
Nplate
Romiplostim
Promacta / Revolade
Eltrombopag
Takhzyro
Lanadelumab
Orladeyo
Berotralstat
Darzalex / Darzalex Faspro
Daratumumab; Daratumumab + Hyaluronidase